Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2020-03, Vol.177 (6), p.1453-1453
1. Verfasser: Ge
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1453
container_issue 6
container_start_page 1453
container_title British journal of pharmacology
container_volume 177
creator Ge
description
doi_str_mv 10.1111/bph.15029
format Article
fullrecord <record><control><sourceid>webofscience</sourceid><recordid>TN_cdi_webofscience_primary_000522634100016CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>000522634100016</sourcerecordid><originalsourceid>FETCH-webofscience_primary_0005226341000163</originalsourceid><addsrcrecordid>eNqVT01LxDAUDKJgXT34D95RcbvmY9vUc1E8eRL2uKTNaxtpk5Ckikf_uUH8ATqXeTDDzBtCrhndsYz7zk87VlH-cEIKtpd1WYmGnZKCUipLxprmnFzE-EZpFmVVkK_WxbRaNxuNENAHjBEjTOhVMj0MpgsumghpCm4dJzgcQLtFGVv2zqbMxo7gg0toLPByQW1UQg0vLvWTAI1jUDpHOQs3724GJuUW_AhC8i1wyuntJTkb1Bzx6pc35O7p8bV9Lj-wc0PsDdoejz6YRYXPY95RcV6LPcsXq8WGNH93tyb9vNK61Sbxv6JvIclqgA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)</title><source>Wiley-Blackwell Journals</source><source>PubMed Central Free</source><source>Wiley Free Archive</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Ge</creator><creatorcontrib>Ge</creatorcontrib><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.15029</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Life Sciences &amp; Biomedicine ; Pharmacology &amp; Pharmacy ; Science &amp; Technology</subject><ispartof>British journal of pharmacology, 2020-03, Vol.177 (6), p.1453-1453</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>0</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000522634100016</woscitedreferencesoriginalsourcerecordid><cites>FETCH-webofscience_primary_0005226341000163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930,28253</link.rule.ids></links><search><creatorcontrib>Ge</creatorcontrib><title>Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)</title><title>British journal of pharmacology</title><addtitle>BRIT J PHARMACOL</addtitle><subject>Life Sciences &amp; Biomedicine</subject><subject>Pharmacology &amp; Pharmacy</subject><subject>Science &amp; Technology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqVT01LxDAUDKJgXT34D95RcbvmY9vUc1E8eRL2uKTNaxtpk5Ckikf_uUH8ATqXeTDDzBtCrhndsYz7zk87VlH-cEIKtpd1WYmGnZKCUipLxprmnFzE-EZpFmVVkK_WxbRaNxuNENAHjBEjTOhVMj0MpgsumghpCm4dJzgcQLtFGVv2zqbMxo7gg0toLPByQW1UQg0vLvWTAI1jUDpHOQs3724GJuUW_AhC8i1wyuntJTkb1Bzx6pc35O7p8bV9Lj-wc0PsDdoejz6YRYXPY95RcV6LPcsXq8WGNH93tyb9vNK61Sbxv6JvIclqgA</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Ge</creator><general>Wiley</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope></search><sort><creationdate>20200301</creationdate><title>Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)</title><author>Ge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-webofscience_primary_0005226341000163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Life Sciences &amp; Biomedicine</topic><topic>Pharmacology &amp; Pharmacy</topic><topic>Science &amp; Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ge</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)</atitle><jtitle>British journal of pharmacology</jtitle><stitle>BRIT J PHARMACOL</stitle><date>2020-03-01</date><risdate>2020</risdate><volume>177</volume><issue>6</issue><spage>1453</spage><epage>1453</epage><pages>1453-1453</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><cop>HOBOKEN</cop><pub>Wiley</pub><doi>10.1111/bph.15029</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2020-03, Vol.177 (6), p.1453-1453
issn 0007-1188
1476-5381
language eng
recordid cdi_webofscience_primary_000522634100016CitationCount
source Wiley-Blackwell Journals; PubMed Central Free; Wiley Free Archive; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Life Sciences & Biomedicine
Pharmacology & Pharmacy
Science & Technology
title Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation (vol 177, pg 372, 2020)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T18%3A42%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-webofscience&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Costunolide%20represses%20hepatic%20fibrosis%20through%20WW%20domain-containing%20protein%202-mediated%20Notch3%20degradation%20(vol%20177,%20pg%20372,%202020)&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Ge&rft.date=2020-03-01&rft.volume=177&rft.issue=6&rft.spage=1453&rft.epage=1453&rft.pages=1453-1453&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.15029&rft_dat=%3Cwebofscience%3E000522634100016%3C/webofscience%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true